Kingsley Chin, MD, is stepping down as CEO of NanoFuse Biologics following the company's merger into a newly formed medtech company.
NanoFuse Biologics, Inspan and Sacrix merged into Nanisx to push minimally invasive spine technologies. A CEO for Nanisx is expected to be announced in the near future.
NanoFuse Biologics focuses on bone healing and fusion with a fiber-based bioactive glass combined with a demineralized bone matrix. The company merged to form Nanisx to help build its team and expand its market share in orthobiologics.